ClinicalTrials.Veeva

Menu

Psyco Quality of Life and Procreation BRCA1/2 (QoL)

R

Regina Elena Cancer Institute

Status

Enrolling

Conditions

Breast Cancer
Genetic Predisposition

Treatments

Behavioral: Genetic predisposition to breast cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05857670
RS1702/22

Details and patient eligibility

About

Women with breast and/or ovarian cancer or with a family history carried these pathologies can makeo genetic counseling in order to investigate whether they are carriers of the BRCA1/2 genetic mutation. This mutation exposes them to develop breast cancer from 50 to 80% and from 27 to 65% of developing ovarian cancer. BRCA1/2 mutations are inherited as an autosomal dominant manner and therefore there is a 50% probability of transmitting the mutation to the progeny. For this reason, women who have BRCA 1/2 mutation may be less likely to want children than those who test negative. The decision to have children could worry both for the probability to transfer the genetic mutation or because the parenthood could be compromised by the illness and/or by premature death. In previous studies, the psychological condition of patients with BRCA 1/2 mutations, with or without children, was only partially investigated. For this reason the main goal of the study is to deeply investigate the specific psychological condition, with particular attention to the guilt feelings on the possibility to transfer the genetic mutation to the progeny. In this wai it could be useful to development a therapeutic strategies aimed at the best adaptation of the patients to the new health condition.

Enrollment

200 estimated patients

Sex

Female

Ages

25 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women with BRCA1/2 mutation affected or not by breast neoplasm
  • Women with BRCA1/2 mutation affected or not by breast neoplasm and with at least a son/daughter
  • Women with at list middle school diploma
  • Women available to do interviews

Exclusion criteria

  • Women with other oncological pathology
  • Women with cognitive deficient and/or inability to comply to the requirements of the study

Trial contacts and locations

2

Loading...

Central trial contact

Anita Caruso

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems